Mitsubishi UFJ Asset Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $157K | Sell |
138,900
-125,165
| -47% | -$141K | ﹤0.01% | 1012 |
|
|
2025
Q1 | $386K | Buy |
264,065
+10,489
| +4% | +$15.3K | ﹤0.01% | 875 |
|
|
2024
Q4 | $548K | Buy |
253,576
+16,880
| +7% | +$36.5K | ﹤0.01% | 861 |
|
|
2024
Q3 | $663K | Sell |
236,696
-9,238
| -4% | -$25.9K | ﹤0.01% | 835 |
|
|
2024
Q2 | $573K | Buy |
245,934
+28,439
| +13% | +$66.3K | ﹤0.01% | 834 |
|
|
2024
Q1 | $972K | Sell |
217,495
-3,599
| -2% | -$16.1K | ﹤0.01% | 807 |
|
|
2023
Q4 | $736K | Buy |
221,094
+37,131
| +20% | +$124K | ﹤0.01% | 843 |
|
|
2023
Q3 | $583K | Hold |
183,963
| – | – | ﹤0.01% | 875 |
|
|
2023
Q2 | $914K | Buy |
183,963
+18,585
| +11% | +$92.4K | ﹤0.01% | 828 |
|
|
2023
Q1 | $817K | Buy |
165,378
+1,933
| +1% | +$9.55K | ﹤0.01% | 840 |
|
|
2022
Q4 | $941K | Sell |
163,445
-8,778
| -5% | -$50.6K | ﹤0.01% | 813 |
|
|
2022
Q3 | $1.86M | Buy |
172,223
+481
| +0.3% | +$5.2K | 0.01% | 709 |
|
|
2022
Q2 | $1.96M | Buy |
171,742
+15,042
| +10% | +$171K | 0.01% | 713 |
|
|
2022
Q1 | $1.43M | Buy |
156,700
+1,874
| +1% | +$17.1K | 0.01% | 791 |
|
|
2021
Q4 | $2.37M | Buy |
154,826
+53,453
| +53% | +$817K | 0.01% | 723 |
|
|
2021
Q3 | $2.61M | Hold |
101,373
| – | – | 0.01% | 692 |
|
|
2021
Q2 | $2.64M | Buy |
101,373
+41,688
| +70% | +$1.09M | 0.01% | 689 |
|
|
2021
Q1 | $2.11M | Buy |
59,685
+3,785
| +7% | +$134K | 0.01% | 683 |
|
|
2020
Q4 | $1.41M | Buy |
55,900
+25,187
| +82% | +$636K | 0.01% | 714 |
|
|
2020
Q3 | $1.16M | Buy |
30,713
+11,366
| +59% | +$429K | 0.01% | 695 |
|
|
2020
Q2 | $828K | Sell |
19,347
-21,638
| -53% | -$926K | 0.01% | 719 |
|
|
2020
Q1 | $797K | Buy |
40,985
+17,110
| +72% | +$333K | 0.01% | 663 |
|
|
2019
Q4 | $620K | Buy |
23,875
+18,712
| +362% | +$486K | 0.01% | 758 |
|
|
2019
Q3 | $141K | Buy |
5,163
+994
| +24% | +$27.1K | ﹤0.01% | 870 |
|
|
2019
Q2 | $112K | Buy |
+4,169
| New | +$112K | ﹤0.01% | 907 |
|